Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    9375704 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
Conditions: Acute Myocardial Infarction;   Acute Kidney Injury
Interventions: Drug: Sodium bicarbonate plus NAC;   Drug: Saline hydration plus NAC
2 Enrolling by invitation RenalGuard System and Contrast Media
Condition: Chronic Kidney Disease
Interventions: Device: RenalGuard system;   Drug: Sodium Bicarbonate and N-acetylcysteine
3 Enrolling by invitation Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
Condition: Chronic Kidney Disease
Intervention: Drug: Physiological Saline, N-Acetylcysteine and Sodium Bicarbonate
4 Active, not recruiting Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy
Condition: Contrast Media Induced Nephropathy (CIN)
Interventions: Other: application of intravenous volume;   Other: oral fluid application
5 Completed Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
Conditions: Contrast Induced Nephropathy;   Kidney Diseases
Intervention: Drug: Sodium bicarbonate

Indicates status has not been verified in more than two years